MyFinsight
Home
About
Contact
cldx: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, CLDX has $648,439K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
648,439
692,407
Total stockholders' equity
598,363
655,406
Total liabilities and stockholders' equity
648,439
692,407
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Maturing after one year
through three...
$32,252K
Maturing in one year or
less-Corporate Debt Securities
$305,897K
Maturing after one year
through three...
$54,939K
Maturing in one year or
less-USTreasury And Government
$154,098K
Prepaid and other
current assets
$21,026K
Accounts and other
receivables
$90K
Marketable securities
$547,186K
Cash and cash
equivalents
$36,037K
Other assets
$9,364K
Intangible assets
$27,190K
Operating lease
right-of-use assets, net
$2,717K
Property and equipment,
net
$4,829K
Total current assets
$604,339K
Total assets
$648,439K
Total liabilities and
stockholders' equity
$648,439K
Total stockholders'
equity
$598,363K
Total liabilities
$50,076K
Accumulated deficit
-$1,732,664K
Accumulated other
comprehensive income
$3,765K
Additional paid-in capital
$2,327,196K
Other long-term
liabilities
$2,543K
Long-term portion of
operating lease...
$1,068K
Total current
liabilities
$46,465K
Common stock, .001 par
value 297,000,000...
$66K
Current portion of other
long-term liabilities
$930K
Current portion of
operating lease...
$1,553K
Accrued expenses
$39,715K
Accounts payable
$4,267K
Buy me a coffee
Celldex Therapeutics, Inc. (CLDX)
Celldex Therapeutics, Inc. (CLDX)